Boston, Massachusetts 02115


Purpose:

This study will measure plasma concentrations of dexmedetomidine, fentanyl, morphine and midazolam in pediatric patients supported with extracorporeal membrane oxygenation (ECMO) aiming to understand the pharmacokinetics of these drugs in this setting.


Criteria:

Inclusion Criteria: - supported on ECMO - receiving one or a combination of the following drugs dexmedetomidine, fentanyl, midazolam or morphine as part of sedation management Exclusion Criteria:


NCT ID:

NCT03593408


Primary Contact:

Principal Investigator
Viviane Nasr, MD
Boston Children’s Hospital

Viviane Nasr, MD
Phone: 617-355-6225
Email: viviane.nasr@childrens.harvard.edu


Backup Contact:

N/A


Location Contact:

Boston, Massachusetts 02115
United States

Viviane Nasr, MD

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.